Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACNES 3.0 trial of lidocaine trigger-point injections with or without methylprednisolone acetate
NL-OMON24284Not yet recruiting
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in Abdominal Cutaneous Nerve Entrapment Syndrome (ACNES) comparing Lidocaine + methylprednisolone acetate with Lidocaine alone control (2 arms). Primary endpoint: Pain response after second injection. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
lidocainemethylprednisolone
03
Conditions
Abdominal Cutaneous Nerve Entrapment Syndrome (ACNES)
Beyond the preview
Go deeper on NL-OMON24284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24284.